N1539

· Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for N1539, covering 2011-12-02 to 2023-09-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery [Phase 4]